The Hastings Center has published “Benefit-Cost Analysis and Emerging Technologies,” by RSC’s Brian Mannix, as part of a special report funded by the National Science Foundation. The full report explores the governance of newly developed techniques in bioengineering – such as the ability to modify a species in the wild, or render it (a mosquito, for example) extinct. Mannix argues that, properly understood, benefit-cost analysis is an appropriate technique for determining which actions are in the public interest. He also cautions against a “precautionary” approach that would shift the burden onto new technologies to demonstrate safety before they can be used.
Read the full report...